Synergistic Effects of Multi-Kinase Inhibition on <i>LRRK2</i>-G2019S and Alpha-Synuclein Pathologies in Models of Parkinson’s Disease

<b>Introduction</b>: Pathogenic mutations in leucine-rich repeat protein kinase-2 (<i>LRRK2</i>), particularly G2019S, constitute the most common cause of autosomal dominant PD. <b>Methods</b>: Mouse models encoding human mutant alpha-synuclein (<i>SNCA A53T</i>) and <i>LRRK2</i> G2019S were treated...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Xiaoguang Liu, Sean Baxley, Michaeline L. Hebron, Charbel Moussa
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	MDPI AG 2026-04-01
Цуврал:	Biomedicines
Нөхцлүүд:	Parkinson’s disease alpha-synuclein LRRK2 dopamine tyrosine kinase inhibition
Онлайн хандалт:	https://www.mdpi.com/2227-9059/14/4/927
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!